USE OF 5HT4 RECEPTOR ANTAGONIST IN MANUFACTURE OF MEDICAMENT FOR PROPHYLAXIS OR TREATMENT OF ATRIAL FIBRILLATION

PROBLEM TO BE SOLVED: To provide a medicament for the prophylaxis or treatment of heart diseases in a mammal. SOLUTION: The invention relates to the pharmaceutical composition for oral administration of a tablet, a troche agent or a lozenges agent or encapsulated in a hard gelatin capsule as powder...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	GOUT BERNARD EMILE JOSEPH, SHEPHERD GILLIAN LOUISE, PATEL BELA RAJIV, BONHOMME MIREILLE MARGUERITE J, AMIN NEETA BALKRISHAN, BRIL ANTOINE M A, ILSON BERNARD ENNO
Format:	Patent
Sprache:	eng
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	GOUT BERNARD EMILE JOSEPH SHEPHERD GILLIAN LOUISE PATEL BELA RAJIV BONHOMME MIREILLE MARGUERITE J AMIN NEETA BALKRISHAN BRIL ANTOINE M A ILSON BERNARD ENNO
description	PROBLEM TO BE SOLVED: To provide a medicament for the prophylaxis or treatment of heart diseases in a mammal. SOLUTION: The invention relates to the pharmaceutical composition for oral administration of a tablet, a troche agent or a lozenges agent or encapsulated in a hard gelatin capsule as powder or a pellet form containing 50-120 mg (measured as a free base) of a N-[(1-n-butyl-4-piperidinyl) methyl]-3,4-dihydro-2H-[1, 3]oxazino[3, 2-a]indole-10-carboxamide (SB207266) or a pharmaceutically acceptable salt thereof and pharmaceutically acceptable carriers. COPYRIGHT: (C)2007,JPO&INPIT
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JP2007145869A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JP2007145869A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JP2007145869A3</originalsourceid><addsrcrecordid>eNqNyssKwjAQheFuXIj6DoN7oWq9LceY2JE0CdMp6KoUiSvRQn1_LMUHcHX4Od84aatSgzewySUD1koH8QzoBM_eUSlADgp0lUElFQ-00CdSWGgnYHob2If8ZvFKJfQprFGGs6coTGjB0JHJWhTybpqMHs2zi7PfTpK50aLyRWzfdeza5h5f8VNfwipNd8tss98ecP0X-gIwljhQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>USE OF 5HT4 RECEPTOR ANTAGONIST IN MANUFACTURE OF MEDICAMENT FOR PROPHYLAXIS OR TREATMENT OF ATRIAL FIBRILLATION</title><source>esp@cenet</source><creator>GOUT BERNARD EMILE JOSEPH ; SHEPHERD GILLIAN LOUISE ; PATEL BELA RAJIV ; BONHOMME MIREILLE MARGUERITE J ; AMIN NEETA BALKRISHAN ; BRIL ANTOINE M A ; ILSON BERNARD ENNO</creator><creatorcontrib>GOUT BERNARD EMILE JOSEPH ; SHEPHERD GILLIAN LOUISE ; PATEL BELA RAJIV ; BONHOMME MIREILLE MARGUERITE J ; AMIN NEETA BALKRISHAN ; BRIL ANTOINE M A ; ILSON BERNARD ENNO</creatorcontrib><description>PROBLEM TO BE SOLVED: To provide a medicament for the prophylaxis or treatment of heart diseases in a mammal. SOLUTION: The invention relates to the pharmaceutical composition for oral administration of a tablet, a troche agent or a lozenges agent or encapsulated in a hard gelatin capsule as powder or a pellet form containing 50-120 mg (measured as a free base) of a N-[(1-n-butyl-4-piperidinyl) methyl]-3,4-dihydro-2H-[1, 3]oxazino[3, 2-a]indole-10-carboxamide (SB207266) or a pharmaceutically acceptable salt thereof and pharmaceutically acceptable carriers. COPYRIGHT: (C)2007,JPO&INPIT</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2007</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070614&DB=EPODOC&CC=JP&NR=2007145869A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20070614&DB=EPODOC&CC=JP&NR=2007145869A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GOUT BERNARD EMILE JOSEPH</creatorcontrib><creatorcontrib>SHEPHERD GILLIAN LOUISE</creatorcontrib><creatorcontrib>PATEL BELA RAJIV</creatorcontrib><creatorcontrib>BONHOMME MIREILLE MARGUERITE J</creatorcontrib><creatorcontrib>AMIN NEETA BALKRISHAN</creatorcontrib><creatorcontrib>BRIL ANTOINE M A</creatorcontrib><creatorcontrib>ILSON BERNARD ENNO</creatorcontrib><title>USE OF 5HT4 RECEPTOR ANTAGONIST IN MANUFACTURE OF MEDICAMENT FOR PROPHYLAXIS OR TREATMENT OF ATRIAL FIBRILLATION</title><description>PROBLEM TO BE SOLVED: To provide a medicament for the prophylaxis or treatment of heart diseases in a mammal. SOLUTION: The invention relates to the pharmaceutical composition for oral administration of a tablet, a troche agent or a lozenges agent or encapsulated in a hard gelatin capsule as powder or a pellet form containing 50-120 mg (measured as a free base) of a N-[(1-n-butyl-4-piperidinyl) methyl]-3,4-dihydro-2H-[1, 3]oxazino[3, 2-a]indole-10-carboxamide (SB207266) or a pharmaceutically acceptable salt thereof and pharmaceutically acceptable carriers. COPYRIGHT: (C)2007,JPO&INPIT</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2007</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNyssKwjAQheFuXIj6DoN7oWq9LceY2JE0CdMp6KoUiSvRQn1_LMUHcHX4Od84aatSgzewySUD1koH8QzoBM_eUSlADgp0lUElFQ-00CdSWGgnYHob2If8ZvFKJfQprFGGs6coTGjB0JHJWhTybpqMHs2zi7PfTpK50aLyRWzfdeza5h5f8VNfwipNd8tss98ecP0X-gIwljhQ</recordid><startdate>20070614</startdate><enddate>20070614</enddate><creator>GOUT BERNARD EMILE JOSEPH</creator><creator>SHEPHERD GILLIAN LOUISE</creator><creator>PATEL BELA RAJIV</creator><creator>BONHOMME MIREILLE MARGUERITE J</creator><creator>AMIN NEETA BALKRISHAN</creator><creator>BRIL ANTOINE M A</creator><creator>ILSON BERNARD ENNO</creator><scope>EVB</scope></search><sort><creationdate>20070614</creationdate><title>USE OF 5HT4 RECEPTOR ANTAGONIST IN MANUFACTURE OF MEDICAMENT FOR PROPHYLAXIS OR TREATMENT OF ATRIAL FIBRILLATION</title><author>GOUT BERNARD EMILE JOSEPH ; SHEPHERD GILLIAN LOUISE ; PATEL BELA RAJIV ; BONHOMME MIREILLE MARGUERITE J ; AMIN NEETA BALKRISHAN ; BRIL ANTOINE M A ; ILSON BERNARD ENNO</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JP2007145869A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2007</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GOUT BERNARD EMILE JOSEPH</creatorcontrib><creatorcontrib>SHEPHERD GILLIAN LOUISE</creatorcontrib><creatorcontrib>PATEL BELA RAJIV</creatorcontrib><creatorcontrib>BONHOMME MIREILLE MARGUERITE J</creatorcontrib><creatorcontrib>AMIN NEETA BALKRISHAN</creatorcontrib><creatorcontrib>BRIL ANTOINE M A</creatorcontrib><creatorcontrib>ILSON BERNARD ENNO</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GOUT BERNARD EMILE JOSEPH</au><au>SHEPHERD GILLIAN LOUISE</au><au>PATEL BELA RAJIV</au><au>BONHOMME MIREILLE MARGUERITE J</au><au>AMIN NEETA BALKRISHAN</au><au>BRIL ANTOINE M A</au><au>ILSON BERNARD ENNO</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>USE OF 5HT4 RECEPTOR ANTAGONIST IN MANUFACTURE OF MEDICAMENT FOR PROPHYLAXIS OR TREATMENT OF ATRIAL FIBRILLATION</title><date>2007-06-14</date><risdate>2007</risdate><abstract>PROBLEM TO BE SOLVED: To provide a medicament for the prophylaxis or treatment of heart diseases in a mammal. SOLUTION: The invention relates to the pharmaceutical composition for oral administration of a tablet, a troche agent or a lozenges agent or encapsulated in a hard gelatin capsule as powder or a pellet form containing 50-120 mg (measured as a free base) of a N-[(1-n-butyl-4-piperidinyl) methyl]-3,4-dihydro-2H-[1, 3]oxazino[3, 2-a]indole-10-carboxamide (SB207266) or a pharmaceutically acceptable salt thereof and pharmaceutically acceptable carriers. COPYRIGHT: (C)2007,JPO&INPIT</abstract><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	eng
recordid	cdi_epo_espacenet_JP2007145869A
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	USE OF 5HT4 RECEPTOR ANTAGONIST IN MANUFACTURE OF MEDICAMENT FOR PROPHYLAXIS OR TREATMENT OF ATRIAL FIBRILLATION
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T20%3A22%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GOUT%20BERNARD%20EMILE%20JOSEPH&rft.date=2007-06-14&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJP2007145869A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true